LCS
MDT icon

Levin Capital Strategies’s Medtronic MDT Stock Holding History

Levin Capital Strategies’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,113
Closed -$1.37M – 216
2019
Q2 		$1.37M Buy
14,113
+335
+2% +$30.6K 0.14% 80
2019
Q1 		$1.25M Sell
13,778
-60
-0.4% -$5.37K 0.14% 75
2018
Q4 		$1.26M Sell
13,838
-303,650
-96% -$28.4M 0.03% 116
2018
Q3 		$31.2M Sell
317,488
-118,891
-27% -$11M 0.54% 41
2018
Q2 		$37.4M Buy
436,379
+402,629
+1,193% +$33.6M 0.64% 39
2018
Q1 		$2.71M Buy
33,750
+8,050
+31% +$664K 0.05% 98
2017
Q4 		$2.08M Hold
25,700
– – 0.04% 111
2017
Q3 		$2M Hold
25,700
– – 0.03% 107
2017
Q2 		$2.28M Hold
25,700
– – 0.04% 112
2017
Q1 		$2.07M Hold
25,700
– – 0.04% 108
2016
Q4 		$1.83M Sell
25,700
-41,380
-62% -$3.25M 0.03% 129
2016
Q3 		$5.8K Sell
67,080
-18,044
-21% -$1.57M 0.09% 99
2016
Q2 		$7.39M Sell
85,124
-7,854
-8% -$635K 0.13% 85
2016
Q1 		$6.97M Sell
92,978
-10,000
-10% -$753K 0.13% 93
2015
Q4 		$7.92M Sell
102,978
-42,055
-29% -$3.17M 0.14% 94
2015
Q3 		$9.71M Sell
145,033
-122,635
-46% -$9.03M 0.17% 92
2015
Q2 		$19.8M Sell
267,668
-1,430,817
-84% -$109M 0.29% 67
2015
Q1 		$132M Sell
1,698,485
-214,474
-11% -$16.3M 1.98% 14
2014
Q4 		$138M Sell
1,912,959
-462,657
-19% -$32.1M 2.09% 12
2014
Q3 		$147M Buy
2,375,616
+602,982
+34% +$38.3M 2.24% 12
2014
Q2 		$113M Buy
1,772,634
+1,695,709
+2,204% +$103M 1.74% 18
2014
Q1 		$4.73M Sell
76,925
-334,935
-81% -$19.5M 0.08% 132
2013
Q4 		$23.6M Sell
411,860
-854,298
-67% -$48.4M 0.38% 55
2013
Q3 		$67.4M Sell
1,266,158
-2,031,887
-62% -$109M 1.15% 28
2013
Q2 		$170M Buy
+3,298,045
New +$163M 3.06% 5

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Levin Capital Strategies's MDT Position: Q3 2019 in Review

Levin Capital Strategies sold out of Medtronic (MDT) in Q3 2019, closing a stake of 14,113 shares — an estimated $1.37M sold.

Levin Capital Strategies first reported a position in MDT in Q2 2013 and held it in 25 quarters. The position peaked at $170M in Q2 2013. 1,645 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

  • Levin Capital Strategies reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
  • Levin Capital Strategies sold 14,113 Medtronic shares in Q3 2019, an estimated $1.37M.
  • Levin Capital Strategies first reported a position in Medtronic in Q2 2013 and held it in 25 quarters.
  • Levin Capital Strategies's Medtronic position peaked at $170M in Q2 2013.
  • 1,645 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Levin Capital Strategies's 13F filing for Q3 2019, filed 14 Nov 2019.